Search

Home > Lung Cancer Considered > ELCC Highlights - Felip and Barlesi
Podcast: Lung Cancer Considered
Episode:

ELCC Highlights - Felip and Barlesi
Category: Science & Medicine
Duration: 00:26:12
Publish Date: 2021-04-05 12:00:20
Description: This edition of Lung Cancer Considered discusses important science presented at the recently completed European Lung Cancer Congress, the multidisciplinary lung cancer meeting co-organized by ESMO and IASLC. Dr. Enriqueta Felip and Dr. Fabrice Barlesi share their interpretation of the following clinical trials presented at ELCC: Adagrasib (MRTX849) -- phase Ib expansion and phase II monotherapy cohorts CheckMate 9LA -- randomized 719 patients with EGFR/ALK wild type NSCLC to standard chemotherapy or 2 cycles of chemotherapy with nivolumab and Ipilimumab KEYNOTE-407-- randomized squamous NSCLC to carboplatin with choice of nab/ paclitaxel or paclitaxel, and either pembrolizumab or placebo AMG 757-- BiTE: bispecific T-cell engager targeting DLL3 and engaging CD3 CAMEL-sq trial-- phase III randomized trial in patients with advanced squamous NSCLC
Total Play: 0